Omniab Inc (OABI) financials

NASDAQ · Health Care

$5.11 -2.29% Close Oct 30, 2026 Live

Omniab revenue and earnings by year

Omniab's revenue was $18.7 million in the fiscal year to December 31, 2025, down 29.3% from the year before. Net income was -$64.8 million, -347.0% of revenue. Since the fiscal year to December 31, 2019, revenue has grown 0.3% a year on average.

RevenueNet income
-$50.0M$0$50.0M
2019202020212022202320242025

Fiscal years, each labelled by the calendar year it ended in.

Income statement, the last 7 fiscal years

In millions of US dollars except per-share figures. Each column is a fiscal year, named by the month it ended.
Fiscal year toDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Revenue19263459352318
Revenue growth-29.3%-22.8%-42.2%70.0%49.3%27.0%—
Operating income-69-75-69-27-36-26-13
Operating margin-369.5%-282.3%-203.2%-45.1%-102.5%-110.1%-71.1%
Net income-65-62-51-22-27-18-14
Net margin-347.0%-235.1%-148.2%-37.8%-77.8%-75.5%-74.2%
Diluted EPS-$0.57-$0.61-$0.51-$0.26-$0.33——
Free cash flow-37-421-21-102-5

Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open OABI in Markets.

How Omniab makes money

Revenue by segment in the quarter to June 30, 2026, as the company reports it.

SegmentRevenueShare
License & Milestone Revenue$9.52M70.9%
Services$2.47M18.4%
X Ploration Revenue$1.16M8.7%
Royalty$266K2.0%

See also: OABI returns

No forecast, no recommendation. This page describes Omniab Inc from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.